Intellia Therapeutics
NTLA
NTLA
156 hedge funds and large institutions have $789M invested in Intellia Therapeutics in 2018 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 55 increasing their positions, 29 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
16% more call options, than puts
Call options by funds: $7.78M | Put options by funds: $6.72M
4.65% more ownership
Funds ownership: 62.31% → 66.97% (+4.7%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
156
Holding in Top 10
3
Calls
$7.78M
Puts
$6.72M
Top Buyers
| 1 | +$31.6M | |
| 2 | +$24.9M | |
| 3 | +$22.8M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.74M |
| 5 |
Morgan Stanley
New York
|
+$8.87M |
Top Sellers
| 1 | -$33.4M | |
| 2 | -$12.1M | |
| 3 | -$7.85M | |
| 4 |
O
OrbiMed
New York
|
-$6.48M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$5.66M |